Advertisement
News
Subscribe to MDT Magazine News

New patient guidelines for heart devices

April 16, 2011 6:37 am | by EurekAlert | Comments

(Henry Ford Health System) A series of new guidelines for cardiac specialists has been developed to determine when heart failure patients should receive a mechanical heart-pumping device.

TOPICS:

Health care-associated infections are exacerbated by alcohol use disorders(2)

April 15, 2011 2:36 pm | by EurekAlert | Comments

(Alcoholism: Clinical & Experimental Research) Health care-associated infections (HAIs) are infections that patients acquire during their hospitalization and that were not present at the time of admission to the hospital. A new study has found that people with alcohol use disorders...

TOPICS:

MedPAC Vote Could Mean Less Innovation for Imaging Devices

April 15, 2011 2:30 pm | by U.S. Food & Drug Administration | Comments

Recommendations from the Medicare Payment Advisory Commission (MedPAC) could curtail use of medical imaging devices.

TOPICS:
Advertisement

eSource Guidance Doesn & #8217;t Reflect Current Practice, Industry Says

April 15, 2011 2:30 pm | by U.S. Food & Drug Administration | Comments

Manufacturers commenting on an FDA draft guidance addressing electronic data from clinical trials say the guidance is out of sync with current capabilities and practices for data capture and lacks information about the sponsor’s role in reviewing data.

TOPICS:

Alkermes' diabetes treatment boosted in Europe

April 15, 2011 1:38 pm | by Mass High Tech: The Journal of New England Technology | Comments

Alkermes Inc. has received a positive opinion from a key European regulatory committee for its experimental diabetes treatment, Bydureon. The recommendation means the drug candidate is very likely to be approved there.

TOPICS:

Health care-associated infections are exacerbated by alcohol use disorders

April 15, 2011 1:37 pm | Comments

Alcoholism: Clinical & Experimental Research

FDA Approves New Medical Device for Form of Brain Cancer

April 15, 2011 11:35 am | by Bio-Medicine.Org | Comments

SILVER SPRING, Md., April 15, 2011 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration recently approved the NovoTTF-100A System, a new device to treat adults with glioblastoma multiforme (GBM) that recurs or progresses after receiving chemotherapy and radiation therapy....

TOPICS:

TSX-listed corporate dividends and distributions declared April 15, 2011

April 15, 2011 10:45 am | by The Associated Press | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on April 15, 2011.Ishares Us Hi Yld Bnd Indx Fnd(cad-hdg)etf (TSX:XHY): $0.12842. Payable Mar 31. Record Mar 29.Arc Resources Ltd. (TSX:ARX): $0.1. Payable May 16. Record Apr...

Advertisement

Thermo Fisher Scientific launches new near-infrared spectrometer for pharmaceutical processing

April 15, 2011 9:37 am | by I-Micronews | Comments

Thermo Fisher Scientific Inc., the world leader in serving science, today announced the new Thermo Scientific TruProcess analyzer, the next-generation near-infrared (NIR) spectrometer for real-time blend analysis, drying and other process analytical technology (PAT) applications.

SVTC Technologies awarded $25M grant from U.S. DOE to build nation?s first photovoltaic manufacturing development facility

April 15, 2011 9:37 am | by I-Micronews | Comments

Grant to support DOE?s goal of cutting costs of PV systems by 75% before the end of the decade.

IntelliCentrics, Inc. Acquires Hospital Vendor Credentialing Solution Status Blue, LLC

April 15, 2011 9:35 am | by Bio-Medicine.Org | Comments

DALLAS, April 15, 2011 /- IntelliCentrics, Inc., owner and operator of both Reptrax and VendorClear, announced today the acquisition of Status Blue, LLC, a leading vendor compliance solution. With the acquisition of Status Blue, LLC, IntelliCentrics will unite the majority of the...

TOPICS:

FDA Approves the NovoTTF-100A System for the Treatment of Patients With Recurrent Glioblastoma Multiforme (GBM) Brain Tumors

April 15, 2011 9:32 am | by Bio-Medicine.Org | Comments

WASHINGTON, April 15, 2011 /- Novocure today announced that the U.S. Food and Drug Administration (FDA) approved the NovoTTF-100A System (NovoTTF) for the treatment of adult patients with glioblastoma multiforme (GBM) brain tumors, following tumor recurrence after receiving chemotherapy....

TOPICS:

Court refuses last Scrushy appeal of $2.9B verdict

April 15, 2011 8:45 am | by The Associated Press | Comments

The Alabama Supreme Court has rejected Richard Scrushy's final appeal of a $2.9 billion verdict over the huge fraud that occurred while he was running HealthSouth Corp.The justices refused to rehear Scrushy's last-ditch appeal in a decision released Friday.A judge in Birmingham ruled in a civil...

ERT Reports First Quarter 2011 Operating Results on May 2, 2011

April 15, 2011 6:33 am | by Bio-Medicine.Org | Comments

PHILADELPHIA, April 15, 2011 /- ERT (Nasdaq: ERES ) announced today that it will release its operating results for the first quarter 2011 Monday, May 2, after the market closes. After the release, the Company will host a conference call at 5:00 PM ET that day. For the conference call,...

TOPICS:

Lansoprazole Delayed-Release Orally Disintegrating Tablets by Teva Pharmaceuticals: Letter to Healthcare Professionals - Clogged, Blocked Oral Syringes and Feeding Tubes

April 15, 2011 6:30 am | by U.S. Food & Drug Administration | Comments

Tablets may not fully disintegrate when water is added, and/or they may disintegrate but later form clumps which can adhere to the inside walls of oral syringes and feeding tubes.

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading